Prevalence of cervical intraepithelial neoplasia and cervical carcinoma in a tertiary care hospital at Rajshahi
DOI:
https://doi.org/10.18203/2320-6012.ijrms20233972Keywords:
HPV, Prevalence, CIN, Cervical carcinomaAbstract
Background: Cervical intraepithelial neoplasia (CIN) is a precancerous cervical condition with the potential to develop into cervical carcinoma if untreated. While research on CIN and cervical carcinoma exists in various regions, the Rajshahi area lacks such investigations. Examining the prevalence of CIN and cervical carcinoma in this region is essential. This study aimed to assess the prevalence of CIN and cervical carcinoma in a tertiary care hospital at Rajshahi in Bangladesh.
Methods: This cross-sectional descriptive study was conducted at the department of pathology, Rajshahi medical college, and the department of gynaecology and obstetrics, Rajshahi medical college hospital, Rajshahi, Bangladesh from July 2019 to June 2022. A total of 1000 VIA test-positive cases of cervical lesions were enrolled as study subjects purposively. Data were processed and analyzed by the MS office tools.
Results: Cervical carcinoma was identified through cytological analysis in 4.6% of cases, with 7.6% exhibiting high-grade squamous intraepithelial lesions (HSIL) and 13.1% showing low-grade squamous intraepithelial lesions (LSIL). Through histopathological analysis, cervical carcinoma found in 5.3% of cases, CIN-grade III (CIN-III) in 7.1%, and CIN-II and CIN-I in 2.2%, 16.4% of cases, respectively. Human papillomavirus (HPV) vaccination rate was 0.70%.
Conclusions: The prevalence of CIN and cervical carcinoma in the Rajshahi region of Bangladesh is alarmingly high. These findings underscore the pressing need for the immediate implementation of a comprehensive vaccination and awareness development program for cervical carcinoma.
References
Farley J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008: Cervical cancer incidence and mortality worldwide in 2008. IARC Case Base 10. Lyon, France: IARC Press. 2010.
Benard Vicki B, Philip EC, Steven AJ, William CH, Jane JK, Jack C et al. Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era. JAMA Oncol. 2017;3(6):833-7.
Uddin AK, Sumon MA, Pervin S, Sharmin F. Cervical Cancer in Bangladesh. S Asian J Cancer. 2023;12(01):036-8.
Basu P, Chowdhury D. Cervical cancer screening and HPV vaccination: a comprehensive approach to cervical control. Indian J Med Res. 2009;130(3):241-6.
Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005;116(4):617-23.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer. 2013.
Khanam A, Zannatul FJ, Fauzia B, Akhter N, Akter M, Shamsun N et al. Prevalence of Cervical Intraepithelial Neoplasia (CIN) at Khulna Division of Bangladesh. Bangl J Obstetr Gynaecol. 2018;33(1):21-8.
Strategic framework for the Comprehensive Control of Cancer Cervix in South-East Asia Region. World Health Organization. 2015.
Nessa A, Khanom Q, Ripa SZ, Khan KH, Azad AK, Kamal M. Present status of cervical cancer screening in Bangladesh. J Histopathol Cytopathol. 2019;3(1):45-52.
Emmanuela GSN, Ziad OZ. Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities. PLOS One. 2008;5(6):0863-7.
Saurabh B, Ganesh B, Abhinendra K, Aanchal J. Cancer screening- should cancer screening be essential component of primary health care in developing country? Int J Prev Med. 2015;6:56.
Yang A, Jeang J, Cheng K, Cheng T, Yang B, Wu TC et al. Current state in the development of candidate therapeutic HPV vaccines. Expert Rev Vaccines. 2016;15(8):989-1007.
Laurent JS, Luckett R, Feldman S. HPV vaccination and the effects on rates of HPV-related cancers. Curr Probl Cancer. 2018;42(5):493-506.
Dillner J, Arbyn M, Unger E, Dillner LJC, Immunology E. Monitoring of human papillomavirus vaccination. Clin Exp Immunol. 2011;163(1):17-25.
Kleinsorge F, Schmidmayr M. Human Papillomavirus infection bei Frauen. Gynäkol Onkol. 2018;57(12):1445-51.
Daniyal M, Akhtar N, Ahmad S, Fatima U, Akram M, Asif HM. Update knowledge on cervical cancer incidence and prevalence in Asia. Asian Pacific J Cancer Prevention. 2015;16(9):3617-20.
Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R et al. Recommendations for cervical cancer prevention in Asia Pacific. Vaccine. 2008;26:M89-98.
Hoque MR, Haque E, Karim MR. Cervical cancer in low‐income countries: A Bangladeshi perspective. Int J Gynecol Obstetr. 2021;152(1):19-25.
Kalsoom F, Abeer, Madiha I, Rubina F, Asma Q, Asima N. Histopathological Features of Cervical Cancer in a Central Diagnostic Facility Center in Lahore. PJMHS. 2020;14(4):1-4.
Ameya G, Yerakly F. Characteristics of cervical disease among symptomatic women with histopathological sample at Hawassa University referral hospital, Southern Ethiopia. BMC Women’s Health. 2017;17(1):91.
Castle PE. HPV testing for cervical cancer: the good, the bad, and the ugly. Nature Rev Clin Oncol. 2010;7(7):364-5.
Chowdhury S, Ara R, Roy S, Tanvir SM, Eva FN, Neela TM et al. Knowledge, attitude, and practices regarding human papillomavirus and its’ vaccination among the young medical professionals and students of Bangladesh. Clin Experimental Vaccine Res. 2022;11(1):63.
Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V et al. Examining the association between socioeconomic status and potential human papillomavirus‐associated cancers. Cancer. 2008;113(S10):2910-8.
Parikh S, Brennan P, Boffetta P. Meta‐analysis of social inequality and the risk of cervical cancer. In J Cancer. 2003;105(5):687-91.
Khalaf MK, Rasheed FA, Hussain SA. Association between early marriage and other sociomedical characteristics with the cervical pap smear results in Iraqi women. Adv Sexual Med. 2015;5(04):73.
Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG et al. A case-control study of risk factors for invasive cervical cancer among US women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prevention. 2004;13(10):1574-82.
Arbyn M, Xu L, Simoens C, Martin‐Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Systematic Rev. 2018;5(5):CD009069.
National Strategy for Cervical Cancer Prevention and Control in Bangladesh, 2017-2022. WHO 2022. Available at: https://www.who.int/Bangladesh/news/detail/24-09-2017-national-strategy-for-cervical-cancer-prevention-and-control-in-bangladesh-2017-2022. Accessed on 19 August, 2023.
Parmar T, Kaur J, Sultana F, Vu T, Vu T. Cervical Cancer Prevention in Bangladesh: Awareness and Accessibility to Preventive Methods: A Systematic Review. Proceedings of the 5th International Conference on Natural Sciences and Technology (ICNST’18) 2018, Asian University for Women, Chittagong, Bangladesh. iLab-Australia. 2018;74-8.
